ロード中...
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogs, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs by targeting the viral polymerases. However, the underl...
保存先:
| 出版年: | Innovation (Camb) |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834001/ https://ncbi.nlm.nih.gov/pubmed/33521757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xinn.2021.100080 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|